LON:OBI Ondine Biomedical (OBI) Share Price, News & Analysis C$14.70 -0.05 (-0.34%) As of 05:13 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsHeadlinesBuy This Stock About Ondine Biomedical Stock (LON:OBI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Ondine Biomedical alerts:Sign Up Key Stats Today's RangeC$14.70▼C$14.7550-Day RangeC$11.10▼C$15.3852-Week RangeC$7.50▼C$18.50Volume1.07 million shsAverage Volume453,339 shsMarket CapitalizationC$7.64 billionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens. Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings. We are focused on solutions that address significant needs, are easy to deploy, are environmentally safe, provide substantial public health benefits, and cost a fraction of the infections they target. Our photodisinfection technology has been used successfully for many years in more than 100,000 patient treatments in hospitals, clinics, and industrial settings across Canada. Read More Receive OBI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ondine Biomedical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OBI Stock News HeadlinesOndine Biomedical Sets Virtual 2026 AGM to Confirm Board and AuditorJune 4, 2026 | tipranks.comOndine Biomedical sets date for 2025 results and investor presentationMay 28, 2026 | tipranks.comSolar is dead. Here’s what replaces it.Starting July 4th, every new solar and wind project in America loses its federal tax credits. But one zero-carbon energy source retains full government backing for eight more years - and it runs around the clock without batteries. Investment in this sector has surged 100x in seven years. The Pentagon named it a top energy priority, California mandated it, and Google, Meta, and Berkshire Hathaway are already under contract. One company controls the entire chain from the ground to the grid.June 24 at 1:00 AM | Behind the Markets (Ad)Ondine Biomedical Inc Common Share OBIMay 21, 2026 | morningstar.comMLight-Based Nasal Therapy Trial Completion Puts Ondine on Investors’ RadarMay 12, 2026 | tipranks.comOndine to Spotlight Long-Term Infection Control Gains from Steriwave at Global CongressApril 22, 2026 | tipranks.comOndine Biomedical shares rise 8% as ICU study shows nasal photodisinfection cuts pneumonia rates by nearly 40%April 14, 2026 | finance.yahoo.comOndine’s Steriwave Chosen for Infection Control at New CAD$1.4bn Cowichan HospitalJanuary 27, 2026 | tipranks.comSee More Headlines OBI Stock Analysis - Frequently Asked Questions How have OBI shares performed this year? Ondine Biomedical's stock was trading at C$8.75 at the beginning of the year. Since then, OBI shares have increased by 68.0% and is now trading at C$14.70. How do I buy shares of Ondine Biomedical? Shares of OBI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Ondine Biomedical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Ondine Biomedical investors own include AutoZone (AZO), Intel (INTC), Premier African Minerals (PREM), Rolls-Royce Holdings plc (RR), TJX Companies (TJX), Abacus Health Products (ABAHF) and Aurora Cannabis (ACB). Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:OBI Previous SymbolLON:OBI CIKN/A Webwww.ondinebio.com Phone604-669-0555FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)C($7.00) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-C$424.66 thousand Net Margins-1,117.06% Pretax MarginN/A Return on Equity-1,411.54% Return on Assets-159.71% Debt Debt-to-Equity Ratio11.85 Current Ratio1.23 Quick Ratio8.26 Sales & Book Value Annual SalesC$2.05 million Price / Sales3,727.38 Cash FlowC$7.38 per share Price / Cash Flow1.99 Book ValueC$0.01 per share Price / Book1,702.44Miscellaneous Outstanding Shares519,551,000Free FloatN/AMarket CapC$7.64 billion OptionableNot Optionable Beta0.32 7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (LON:OBI) was last updated on 6/24/2026 by MarketBeat.com Staff. From Our PartnersFirm That Predicted 2008, 2020, 2022: Right Now Looks WorseThe firm that predicted the dot-com crash, the 2008 financial crisis, the 2020 COVID crash, and the 2022 bear ...TradeSmith | SponsoredThe Treasury just bought its own debtOn April 16th, the U.S. Treasury executed a $15 billion buyback of its own debt - the largest in history - whi...Golden Portfolio | SponsoredBlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely, LLC | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredPH: Do THESE 4 things to your bank account now …In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...Weiss Ratings | SponsoredVWAV: An Under-the-Radar Defense PlayVisionWave Holdings (NASDAQ: VWAV) is developing a multi-domain defense platform combining AI-powered analytic...Equiscreen | SponsoredThe fastest-growing business in capitalism's historyWhile investors were focused on the SpaceX IPO, Elon Musk quietly began backing a new AI startup - one that's ...Brownstone Research | SponsoredMy feud with Zohran MamdaniNearly 40% of Americans now hold a positive view of socialism - and former hedge fund manager Whitney Tilson s...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ondine Biomedical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ondine Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
